APA
Folegatti P. M., Bittaye M., Flaxman A., Lopez F. R., Bellamy D., Kupke A., Mair C., Makinson R., Sheridan J., Rohde C., Halwe S., Jeong Y., Park Y., Kim J., Song M., Boyd A., Tran N., Silman D., Poulton I., Datoo M., Marshall J., Themistocleous Y., Lawrie A., Roberts R., Berrie E., Becker S., Lambe T., Hill A., Ewer K. & Gilbert S. (20200909). Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. : The Lancet. Infectious diseases.
Chicago
Folegatti Pedro M, Bittaye Mustapha, Flaxman Amy, Lopez Fernando Ramos, Bellamy Duncan, Kupke Alexandra, Mair Catherine, Makinson Rebecca, Sheridan Jonathan, Rohde Cornelius, Halwe Sandro, Jeong Yuji, Park Young-Shin, Kim Jae-Ouk, Song Manki, Boyd Amy, Tran Nguyen, Silman Daniel, Poulton Ian, Datoo Mehreen, Marshall Julia, Themistocleous Yrene, Lawrie Alison, Roberts Rachel, Berrie Eleanor, Becker Stephan, Lambe Teresa, Hill Adrian, Ewer Katie and Gilbert Sarah. 20200909. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. : The Lancet. Infectious diseases.
Harvard
Folegatti P. M., Bittaye M., Flaxman A., Lopez F. R., Bellamy D., Kupke A., Mair C., Makinson R., Sheridan J., Rohde C., Halwe S., Jeong Y., Park Y., Kim J., Song M., Boyd A., Tran N., Silman D., Poulton I., Datoo M., Marshall J., Themistocleous Y., Lawrie A., Roberts R., Berrie E., Becker S., Lambe T., Hill A., Ewer K. and Gilbert S. (20200909). Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. : The Lancet. Infectious diseases.
MLA
Folegatti Pedro M, Bittaye Mustapha, Flaxman Amy, Lopez Fernando Ramos, Bellamy Duncan, Kupke Alexandra, Mair Catherine, Makinson Rebecca, Sheridan Jonathan, Rohde Cornelius, Halwe Sandro, Jeong Yuji, Park Young-Shin, Kim Jae-Ouk, Song Manki, Boyd Amy, Tran Nguyen, Silman Daniel, Poulton Ian, Datoo Mehreen, Marshall Julia, Themistocleous Yrene, Lawrie Alison, Roberts Rachel, Berrie Eleanor, Becker Stephan, Lambe Teresa, Hill Adrian, Ewer Katie and Gilbert Sarah. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. : The Lancet. Infectious diseases. 20200909.